本页面由Tiger Trade Technology Pte. Ltd.提供服务

Enovis Corporation

27.02
-0.9400-3.36%
盘后27.020.00000.00%18:30 EST
成交量:154.40万
成交额:4,210.66万
市值:15.45亿
市盈率:-1.12
高:28.52
开:28.02
低:26.73
收:27.96
52周最高:49.38
52周最低:25.47
股本:5,718.94万
流通股本:5,645.24万
量比:2.34
换手率:2.74%
股息:- -
股息率:- -
每股收益(TTM):-24.0940
每股收益(LYR):-14.9328
净资产收益率:-51.02%
总资产收益率:0.97%
市净率:0.76
市盈率(LYR):-1.81

数据加载中...

公司资料

公司名字:
Enovis Corporation
交易所:
NYSE
成立时间:
1995
员工人数:
7367
公司地址:
2711 Centerville Road,Suite 400,Wilmington,Delaware,United States
邮编:
19808
电话:
传真:
- -
简介:
Enovis Corporation成立于1995年。该公司是一家创新驱动的医疗技术成长型公司,致力于开发临床差异化解决方案,从而产生更好的患者治疗效果,并改变工作流程。在持续改进全球人才和创新文化的推动下,公司广泛的产品、服务和综合技术都推动了骨科及其他领域积极的生活方式。

董事

名称
职位
Damien McDonald
Chief Executive Officer and Director
A. Clayton Perfall
Independent Director
Angela S. Lalor
Independent Director
Barbara W. Bodem
Independent Director
Brady R. Shirley
Independent Director
Christine Ortiz
Independent Director
Liam Kelly
Independent Director
Philip A. Okala
Independent Director
Rajiv Vinnakota
Independent Director
Sharon L. Wienbar
Independent Chair of the Board

股东

名称
职位
Damien McDonald
Chief Executive Officer and Director
Bradley J. Tandy
Senior Vice President and Chief Legal Officer
Patricia Lang
Senior Vice President and Chief Human Resources Officer
Phillip Berry
Senior Vice President and Chief Financial Officer
Louis Vogt
Group President, Reconstructive
Terry D. Ross
Group President, Prevention & Recovery